title: A drug on the market?
authors.affiliation: Diabetes and Metabolism, Division of Medicine, University of Bristol, Southmead Hospital, UK. Edwin.Gale@bristol.ac.uk
authors.forename: E A
authors.initials: EA
authors.lastname: Gale
authors.forename: A
authors.initials: A
authors.lastname: Clark
mesh_terms: D000682:Amyloid / Q000627:therapeutic use*; D000818:Animals; D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000188:drug therapy*; D003921:Diabetes Mellitus, Experimental / Q000188:drug therapy; D017277:Drug Approval / Q000191:economics*; D004345:Drug Industry / Q000191:economics*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D058228:Islet Amyloid Polypeptide
chemical_list: D000682:Amyloid; D000897:Anti-Ulcer Agents; D007004:Hypoglycemic Agents; D058228:Islet Amyloid Polypeptide